Standard Glass Lining IPO presents an intriguing opportunity for investors, with a book-built issue valued at ₹410.05 crores. The offering consists of a fresh issue of 1.50 crore shares, raising ₹210.0 crores, aimed at funding the company’s growth and operational requirements. Additionally, there is an offer for sale (OFS) of 1.43 crore shares, amounting to ₹200.05 crores, allowing existing shareholders to partially exit their investment. This IPO provides a mix of growth capital and liquidity for stakeholders, making it a noteworthy event for market participants keen on exploring new investment opportunities.
The IPO is open for subscription from 06 January, 2025 and closes on January 08, 2025, offering investors a limited window to participate in this opportunity. The price band is set between ₹133 and ₹140 per share, providing flexibility for bidders within this range. Investors can apply in multiples of the lot size of 107 shares, making the minimum investment more accessible. The minimum fund required for retail investors is ₹14,980. With its structured bidding process and competitive pricing, this IPO is set to attract attention from retail and institutional investors alike.
Refer to Standard Glass Lining IPO RHP for detailed information.
Standard Glass Lining IPO – Apply or Not
The IPO of Standard Glass Lining Technology Limited, valued at ₹410 crore, presents an interesting mix of growth potential and risk. The company has shown strong fundamentals, with a 10% year-on-year revenue increase and a 12% rise in profit after tax (PAT). As a small-sized company, it offers significant opportunities for expansion in the pharmaceutical and chemical engineering sectors, where demand is consistently high. However, the small size also makes it inherently riskier, as it could face challenges in scaling operations or competing with larger players.
The Grey Market Premium (GMP) for the IPO is currently around 60%, suggesting strong investor interest and the possibility of a massive subscription—potentially reaching 100X or 200X. This high demand might make allocation challenging, but those who secure shares should consider holding them for the long term. Given the company’s solid performance and promising prospects, a long-term investment strategy with a proper trailing stop loss can help maximize returns while managing potential risks.
Standard Glass Lining IPO Details
| IPO Date | January 06, 2025 to January 08, 2025 | ||
| Listing Date | 13 January, 2025 | ||
| Face value | ₹10 per share | ||
| Price band | ₹133 to ₹140 per share | ||
| Lot size | 107 Shares | ||
| Total Issue Size | 2,92,89,367 shares (aggregating up to ₹410.05 Cr) | ||
| Fresh Issue | 1,50,00,000 shares (aggregating up to ₹ 210.00 Cr) | ||
| Offer for Sale | 1,42,89,367 shares of ₹10 (aggregating up to ₹200.05 Cr) | ||
| Issue Type | Book Built Issue IPO | ||
| Listing At | BSE, NSE | ||
| Share Holding Post Issue | 19,94,91,662 shares |
Standard Glass Lining IPO Lot Size calculator
| Application | Lots | Share | Amount |
| Retail (Min) | 1 | 107 | ₹14,980 |
| Retail (Max) | 13 | 1,391 | ₹1,94,740 |
| S-HNI (Min) | 14 | 1,498 | ₹2,09,720 |
| S-HNI (Max) | 66 | 7,062 | ₹9,88,680 |
| BS-HNI | 67 | 7,169 | ₹10,03,660 |
Standard Glass Lining IPO Distribution
| Investor Category | Shares Offered |
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
About Standard Glass Lining Company
Standard Glass Lining Technology Limited, started in September 2012, makes engineering equipment for India’s pharmaceutical and chemical industries. The company handles the entire production process in-house.
It offers complete solutions like designing, engineering, manufacturing, assembly, installation, and standard operating procedures for its clients.
Products
- Reaction Systems
- Storage, Separation, and Drying Systems
- Plant, Engineering, and Services
The company specializes in making engineering equipment with materials like glass-lined steel, stainless steel, and nickel alloy.
Customers
Some of its major clients include Apitoria Pharma, Aurobindo Pharma, Cadila Pharmaceuticals, Laurus Labs, Natco Pharma, Hetero Drugs, and many others.
Locations
The company has eight manufacturing units in Hyderabad, Telangana. It also has sales offices in:
- Vadodara and Ankleshwar, Gujarat
- Mumbai, Maharashtra
- Vishakhapatnam, Andhra Pradesh
Its sales team operates in places like Jhagadia, Chennai, New Delhi, Bengaluru, and Vijayawada, ensuring a presence across India.
Workforce
As of September 30, 2024, the company had 460 full-time employees and 731 contract workers.
Competitive Strengths
- Proven history of consistent and profitable growth.
- Experts in engineering equipment for pharma and chemical sectors.
- Custom and innovative solutions for every step of the production process.
- Strategically located, high-tech manufacturing units.
- Strong, long-term relationships with top clients.
Standard Glass Lining Company Finances
Standard Glass Lining Technology Limited saw a 10% rise in revenue and a 12% growth in profit after tax (PAT) between the financial years ending March 31, 2023, and March 31, 2024.
Amount in ₹ Crore
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Total Borrowing | 173.8 | 129.32 | 81.96 | 69.81 |
| Assets | 756.52 | 665.38 | 347.79 | 298.11 |
| Revenue | 312.1 | 549.68 | 500.08 | 241.5 |
| Profit after tax | 36.27 | 60.01 | 53.42 | 25.15 |
| Reserves and Surplus | 261.58 | 389.18 | 139.94 | 53.66 |
| Net Worth | 447.8 | 409.92 | 156.67 | 69.91 |
Standard Glass Lining IPO Prospectus
Read our other articles(IPO Insights)
- FII DII Selling Data, 27 January 2025
- FII DII Selling Data, 24 January 2025
- FII DII Selling Data, 23 January 2025
- FII DII Selling Data, 22 January 2025
- CLN Energy IPO GMP today – Apply or Not
Leave a Reply